Valuation: Bio-View Ltd

Market Cap 11.19M 1.12B 3.73M 3.2M 2.99M 2.74M 5.17M 357M 5.21M 35.38M 13.75M 179M 14M 13.69M 593M P/E 2024
-11.7x
P/E 2025 -1.48x
Enterprise Value 6.76M 676M 2.25M 1.93M 1.81M 1.66M 3.13M 216M 3.15M 21.38M 8.31M 108M 8.46M 8.28M 358M EV / Sales 2024
1.04x
EV / Sales 2025 0.9x
Free-Float
52.06%
Yield 2024 *
-
Yield 2025 -
1 week-2.57%
Current month-7.63%
1 month-6.81%
3 months-39.05%
6 months-53.35%
Current year-50.00%
1 week 83
Extreme 83
86.6
1 month 83
Extreme 83
95.9
Current year 83
Extreme 83
294
1 year 83
Extreme 83
294
3 years 83
Extreme 83
370
5 years 83
Extreme 83
480
10 years 83
Extreme 83
515
Manager TitleAgeSince
Corporate Officer/Principal 64 2009-03-21
Director of Finance/CFO 44 2020-11-30
Chief Operating Officer 49 2010-12-31
Director TitleAgeSince
Chairman 87 2000-03-15
Director/Board Member 63 2015-05-31
Director/Board Member 70 2022-06-27
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.57%-64.16%-74.57% 3.74M
-1.50%+2.36%+23.97%-31.06% 17.87B
-8.93%-15.67%-41.00%+78.67% 1.64B
-1.70%+1.33%-48.06%-82.27% 1.01B
-3.44%-3.02%-24.60%+22.11% 997M
+0.05%+0.16%+59.38%-6.37% 780M
-2.52%-3.93%-38.47%-46.52% 689M
-3.96%-16.13%-45.93%-48.64% 566M
+0.95%+3.34%-39.84%-36.22% 457M
+2.25%+9.09%+69.30%+47.57% 441M
Average -1.88%-1.27%-14.94%-17.73% 2.45B
Weighted average by Cap. -2.01%+1.96%+12.03%-22.40%

Financials

2024 2025
Net sales 25.66M 2.57B 8.55M 7.33M 6.86M 6.28M 11.86M 818M 11.96M 81.11M 31.52M 411M 32.09M 31.39M 1.36B 19.93M 1.99B 6.64M 5.69M 5.33M 4.88M 9.21M 636M 9.29M 63.01M 24.49M 319M 24.93M 24.39M 1.06B
Net income -3.15M -315M -1.05M -899K -842K -771K -1.45M -100M -1.47M -9.95M -3.87M -50.4M -3.94M -3.85M -167M -15.33M -1.53B -5.11M -4.38M -4.1M -3.75M -7.09M -489M -7.15M -48.48M -18.84M -245M -19.18M -18.76M -812M
Net Debt -8.96M -896M -2.98M -2.56M -2.39M -2.19M -4.14M -286M -4.17M -28.32M -11.01M -143M -11.21M -10.96M -475M -4.43M -443M -1.47M -1.26M -1.18M -1.08M -2.05M -141M -2.06M -13.99M -5.44M -70.86M -5.54M -5.42M -235M
Logo Bio-View Ltd
Bio-View Ltd. is an Israel-based company that operates within the medical devices industry. The Company focuses on developing, manufacturing, and marketing automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories. One of the key products offered by the Company is the Accord Plus. This product is an automatic fluorescent imaging system that scans, analyzes, and sorts a range of Fluorescence In Situ Hybridization (FISH) and karyotype samples in real-time. The primary goal of this technology is to facilitate the identification of various chromosomal aberrations, such as amplifications, translocations, inversions, and deletions, under fluorescent light.
Employees
30
Date Price Change Volume
26-08-24 ILA 83.50 0.00% 53
26-08-20 ILA 83.50 -0.24% 3,455
26-08-19 ILA 83.70 -0.24% 4,648
26-08-18 ILA 83.90 -1.18% 11,703
  1. Stock Market
  2. Stocks
  3. BIOV Stock